• 1. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 2. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 3. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 4. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 5. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazinanes Phenylpiperazines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazinanes Piperazines Phenylpiperazines

Introduction to 1-(2-methoxy-4-nitrophenyl)piperazine (CAS No. 170912-81-9)

1-(2-methoxy-4-nitrophenyl)piperazine, identified by its Chemical Abstracts Service (CAS) number 170912-81-9, is a significant compound in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the piperazine class of heterocyclic amines, which are widely recognized for their diverse biological activities and potential therapeutic applications. The structural features of 1-(2-methoxy-4-nitrophenyl)piperazine make it a valuable scaffold for drug discovery, particularly in the development of novel pharmacological agents targeting various neurological and cardiovascular disorders.

The molecular structure of this compound consists of a piperazine ring substituted with a 2-methoxy-4-nitrophenyl group. This phenyl moiety introduces both methoxy and nitro functional groups, which are known to modulate the electronic properties and biological interactions of the molecule. The presence of these substituents enhances the compound's affinity for specific biological targets, making it a promising candidate for further investigation in medicinal chemistry.

In recent years, there has been growing interest in exploring the pharmacological potential of piperazine derivatives, particularly those incorporating aromatic rings with electron-withdrawing or electron-donating groups. The nitro group in 1-(2-methoxy-4-nitrophenyl)piperazine contributes to its reactivity and interaction with biological systems, while the methoxy group provides stability and influences the molecule's solubility and metabolic pathways. These characteristics make it an attractive candidate for further structural optimization and pharmacokinetic studies.

Current research in the field of neuropharmacology has highlighted the importance of piperazine-based compounds in treating conditions such as depression, anxiety, and attention deficit hyperactivity disorder (ADHD). The structural motif of 1-(2-methoxy-4-nitrophenyl)piperazine shares similarities with several known psychoactive agents, suggesting that it may exhibit comparable effects on central nervous system (CNS) receptors. Preliminary studies have indicated that this compound may interact with serotonin receptors, potentially making it useful in the treatment of mood disorders.

Additionally, cardiovascular research has shown that certain piperazine derivatives can influence vascular tone and blood pressure regulation. The unique combination of functional groups in 1-(2-methoxy-4-nitrophenyl)piperazine may enable it to modulate pathways involved in cardiovascular function, offering a new approach to managing conditions such as hypertension and angina. Further investigation into its hemodynamic effects could provide valuable insights into its therapeutic potential.

The synthesis of 1-(2-methoxy-4-nitrophenyl)piperazine involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Advanced synthetic techniques, including palladium-catalyzed cross-coupling reactions and nucleophilic substitution strategies, have been employed to construct the desired molecular framework efficiently. The development of robust synthetic protocols is crucial for scaling up production and conducting extensive pharmacological evaluations.

In terms of pharmacokinetic properties, 1-(2-methoxy-4-nitrophenyl)piperazine exhibits moderate solubility in both aqueous and organic solvents, which is favorable for formulation development. Its metabolic stability has been assessed through in vitro studies using liver microsomes, revealing a profile that suggests potential for oral administration. Understanding these pharmacokinetic parameters is essential for designing effective dosing regimens and minimizing side effects.

Recent advancements in computational chemistry have enabled researchers to predict the biological activity of compounds like 1-(2-methoxy-4-nitrophenyl)piperazine with greater accuracy before conducting costly wet-lab experiments. Molecular docking simulations have been used to identify potential binding interactions with target proteins, providing a rational basis for structure-activity relationship (SAR) studies. These computational approaches have significantly accelerated the drug discovery process.

The safety profile of 1-(2-methoxy-4-nitrophenyl)piperazine is under active investigation to ensure its suitability for clinical development. Preliminary toxicology studies have evaluated acute exposure effects on animal models, providing initial data on its toxicity margins. Long-term studies are necessary to assess chronic effects and potential drug-drug interactions, which are critical steps before human trials can be initiated.

The versatility of 1-(2-methoxy-4-nitrophenyl)piperazine as a pharmacological scaffold has also prompted exploration in other therapeutic areas beyond neurology and cardiology. Its ability to interact with multiple receptor systems suggests potential applications in treating inflammatory diseases, autoimmune disorders, and even cancer. Investigating these broader therapeutic possibilities could open new avenues for medical intervention.

In conclusion, 1-(2-methoxy-4-nitrophenyl)piperazine (CAS No. 170912-81-9) represents a promising compound in pharmaceutical research due to its unique structural features and potential biological activities. Ongoing studies aim to elucidate its mechanisms of action, optimize its synthetic routes, and evaluate its safety profile for future clinical applications. As our understanding of molecular interactions continues to evolve, compounds like this will play an increasingly important role in developing innovative treatments for human diseases.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)